Category INDUSTRY UPDATES

Latin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Latin Clinical Trial Center Becomes Part of PhaseWell Research, Expanding Research and Therapeutic Access PhaseWell Research, a rapidly growing multisite clinical research organization dedicated to expanding access to clinical trials across diverse communities, has announced a strategic partnership with Latin…

Read MoreLatin Clinical Trial Center Joins PhaseWell Research to Strengthen Clinical Research Access in Puerto Rico

Senopsys Celebrates 20 Years of Enhancing Medicine Palatability for Patients Worldwide

Senopsys Celebrates 20 Years of Advancing Patient-Friendly Medicines Through Sensory Science Senopsys, a company recognized for its expertise in sensory science and pharmaceutical palatability solutions, is marking its 20th anniversary of serving the global biopharmaceutical industry. Over the past two…

Read MoreSenopsys Celebrates 20 Years of Enhancing Medicine Palatability for Patients Worldwide

Element Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics

Element Biosciences Raises Upsized Series E to Accelerate Global Expansion Across Genomic, Multiomic, and Clinical Research Solutions Ecosystem Element Biosciences has announced an upsized Series E financing round, anchored by a $175 million investment from long-standing strategic backer Samsung Electronics,…

Read MoreElement Biosciences Upsizes Series E to Accelerate Global Expansion in Genomics and Multiomics

Seek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Seek Labs Maps 25 Viral Families with BioSeeker, Advancing a Sequence-Driven Model for Antiviral Discovery Seek Labs, a private TechBio company focused on developing programmable platforms to decode, program, and ultimately resolve disease mechanisms, has announced a major scientific milestone…

Read MoreSeek Labs Maps 25 Viral Families via BioSeeker, Advancing Sequence-Directed Antiviral Discovery Model

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference

Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its cystic fibrosis (CF) treatment portfolio, particularly ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), across very…

Read MoreVertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference